Target intelligence / Profile preview

U6 small nuclear RNA 7 (RNU6-7)

Target
RNU6-7
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA, RNA component of ribonucleoprotein (snRNP)
01

Overview

U6 small nuclear RNA 7 is one of multiple highly conserved, non-coding small nuclear RNAs that form essential components of the spliceosome—a complex responsible for catalyzing the excision of introns from precursor messenger RNA in eukaryotic nuclei[1][2][3][5]. U6 snRNAs serve as the catalytic core of the spliceosome, directly participating in splicing chemistry and structural rearrangements essential for pre-mRNA processing. Although there are multiple genes and pseudogenes encoding U6 RNAs in the genome (RNU6-1, RNU6-7, etc.), they share near-identical functions. U6 snRNAs are not typical therapeutic targets, but are essential for cell viability and fundamental gene expression. The U6 snRNA gene family is highly conserved, reflecting its critical evolutionary role[1][3][5]. If seeking a drug target or biomarker, U6 snRNA or RNU6-7 is not appropriate as it functions as a ubiquitous, essential RNA for splicing rather than as a modifiable enzyme, receptor, or signaling molecule.

Other names
U6-7RNU6-7U6 small nuclear RNA 7
02

Biological functions

Spliceosome activityPre-mRNA splicingCatalysis of intron removal from precursor mRNA
03

Disease associations

Other (Indirectly essential for viability and gene expression regulation, but not a typical disease biomarker or therapeutic target; some snRNA or spliceosome dysfunction can underlie rare genetic diseases and contribute to cancer through splicing defects, but specific roles for RNU6-7 are not established in pathology)
04

Safety considerations

Disruption of U6 snRNA or global splicing machinery may be lethal or toxic at the cellular level, but there are no known drug-related safety concerns for RNU6-7 in clinical use.

Beyond the preview

Go deeper on U6 small nuclear RNA 7 (RNU6-7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 7 (RNU6-7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call